Emzor Pharmaceutical Industries Limited , an indigenous pan-African manufacturer and distributor of medicines and surgical equipment, among others, has announced its readiness to begin local manufacturing of Active Pharmaceutical Ingredient (API) plant. The move is part of the benefits of Nigeria’s efforts to address the rising cost of drugs and other medical consumables in Nigeria. The facility is expected to commence local production of API before the end of the year, according to the company’s Director of Strategy, Funke Asiru.
Ms Asiru spoke at the Nigeria-EU Business Forum (NEUBF) 9th forum, titled: “Investing in Jobs and Sustainable Future,” organised by EUinNigeria under EU Global Gateway. She said the move aims to improve the country’s healthcare system as the facility will produce APIs for various medicines, including those used to treat malaria and cancer. In April, Emzor announced plans to construct an API facility in Sagamu, Ogun State, worth $23 million (about N25 billion) to combat the pervasive threat of malaria in Nigeria and sub-Saharan Africa.
According to Ms Asiru, the project is being funded by the European Investment Bank (EIB). PREMIUM TIMES delivers fact-based journalism for Nigerians, by Nigerians — and our community of supporters, the readers who donate, make our work possible. Help us bring you and millions of others in-depth, meticulously researched news and information.
It’s essential to acknowledge that news production incurs expense.